SURE CHECK® HIV Self-Test
A CE Marked Chembio single-use in-vitro diagnostic self-test HIV-1 and HIV-2 in fingerstick whole blood.
"I used the Chembio Sure test and Stat view HIV 1/2 point of care assay in our clinic and found it to be very convenient, easy to use and a great way to screen patients with a high quality , sensitive assay . I recommend the test for use as a screening tool for any concerned patients"
GP (Wicklow Clinic, Ireland)
STAT-VIEW® HIV 1/2 Assay One Drop of Blood is All You Need
A CE-Marked, rapid point-of-care test that detects antibodies to HIV-1 and HIV-2 in fingerstick whole blood, venous whole blood, serum and plasma specimens.
Box of 25 pieces
DPP® Syphilis Screen & Confirm
The only rapid point of care test that simultaneously screens and confirms syphilis infection
Box of 20 pieces
DPP® HIV Syphilis Assay Two Assays in One Rapid Test
A CE-Marked, dual rapid test for the detection of antibodies to HIV 1/2 and Treponema pallidum in fingerstick whole blood, venous whole blood, serum, or plasma specimens.
Prevention of mother to child transmission
Infectious Disease Rapid Testing
Launching Soon
The Next Generation of Clinically Approved Rapid Infectious Disease testing including Monkeypox.
INSTI® COVID-19 antibody test
INSTI® COVID-19 antibody test is BioLytical®’s new one-minute rapid test, detecting antibodies to SARS-CoV-2 with high accuracy. BioLytical® has received CE Mark and approval to sell the test across Europe.
INSTI® COVID-19 Antibody Test - Training Video
The world’s first one-minute HCV antibody test
Affecting more than 71 million people, Hepatitis C (HCV) is a growing international health concern. Left untreated, HCV can cause serious health problems including liver damage, liver cancer, and even death.
It doesn't have to be this way. Treatment can cure more than 95% of people with Hepatitis C, but access to diagnosis is far too low.
Ending an epidemic starts with testing. Introducing BioLytical®'s INSTI® HCV antibody test, now CE marked, with FDA approval to follow.
